갑상선 질환에서 갑상선자극호르몬 결합억제 면역글로불린 측정의 의의 및 그 생성장소에 관한 연구
양인명, 김진우, 김영설 et al. · Endocrinology and Metabolism · 1986
To delineate clinical significance of TBII in Graves'' disease and to determine whether thyroid gland is the main site of TBII production, the author performed TBII assay by radioreceptor assay method in 48 patients with Graves'' disease, 8 patients with Hashimoto''s thyroiditis, 13 patients with nontoxic goiter and 21 normal controls. And to find the evidence that the thyroid gland might be source of TBII in Graves'' disease, TBII assay were performed in blood obtained from thyroid vein and a peripheral vein during the operation in 11 patients with Graves'' disease and 3 patients with thyroid cancer. The results were as follows:1) In normal control the mean TBII index was 2.32±3.16. Two standard deviation above mean was approximately 10, so 10 was regarded as the cut-off value of TBII positivity. 2) The positive rate of TBII was 60.42% in patients with Graves'' disease and 12.5% in patieints with Hashimoto''s thyroiditis. There was no detectable case in patients with nontoxic goiter. 3) In Graves'' disease group positive rate of TBII and mean TBII index tend to be decreased with treatment. In untreated group, TBII was positive in 72.72% and mean TBII index was 24.38±23.25, and treated but still active hyperthyroidism group, mean TBII index was 18.67±15.1 and positive in 63.32%, In euthyroid treated group, mean TBII index was decreased to 12.06±5.29 and positive in 38.46%. In group of recurrent Graves'' disease, the mean TBII index was 42.7±24.95. 4) There were no significant correlation between TBII index and serum T3, T4, TSH concentration in patients with Graves'' disease.5) The mean TBII index of thyroid vein of Graves'' disease was 39.1±17.5 and was significantly higher than that of peripheral vein 22.49±19.83. In 2 cases, the TBII were not detectable in peripheral blood but were high level in thyroid vein. Ther were no detectable TBII in peripheral vein and thyroid vein of thyroid cancer.These data reconfirmed are contributed to the pathogenesis of Graves'' disease, and the levels of antibody tend to reflect the activites of underlying disease. Detection of TBII in hypothyroid patients with Hashimoto''s thyroiditis indicated the presence of heterogenous TBII such as blocking antibodies. The TBII index of thyroid vein was higher than that of peripheral which suggested that thyroid gland is the main site of antibody production.
Cited by 15 works.